Researchers working towards a vaccine against COVID-19 at MigVax, an affiliate of the Migal Galilee Research Institute, have announced a $12 million investment to accelerate its efforts.
Jerusalem crowdfunding investment platform OurCrowd led the investment in the Kiryat Shemona research facility.
